MRC – Biomedical Catalyst: Developmental Pathway Funding Scheme (DPFS)

The DPFS scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.

DPFS is an ongoing scheme, with outline deadlines every 4 months.

More information can be found here.